Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Calcium chloride + dextrose + potassium chloride + sodium lactate + sodium chloride** is a parenteral combination electrolyte and carbohydrate crystalloid solution marketed as **Lactated Ringer's and Dextrose Injection**. It is an intravenous fluid replacement product used to provide water, electrolytes, and calories, and to help correct mild metabolic acidosis through the alkalinizing effect of sodium lactate metabolism. The formulation combines sodium and chloride for extracellular fluid replacement, potassium and calcium for electrolyte replenishment, lactate as a bicarbonate precursor, and dextrose as a carbohydrate calorie source and blood glucose substrate. It is a pharmaceutical small-molecule mineral/electrolyte solution rather than a biologic, and has been manufactured by Hospira, now part of Pfizer, for fluid and electrolyte replacement and related supportive care indications in adults and pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride + dextrose + potassium chloride + sodium lactate + sodium chloride.